Archive for December, 2020

$CNSP Announces Pricing of $10M Public Offering

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced the pricing of an underwritten public offering of 5,000,000 shares of common stock and warrants to purchase up to 2,500,000 shares of common stock. According to the update, the shares of common stock and warrants are being sold together at a combined public offering price of $2.00 per share and warrant. The warrants will have an exercise price of $2.20 per share and will be immediately exercisable and expire five years from the issuance date. CNS Pharmaceuticals has granted a 45-day underwriter option for the purchase of up to an additional 750,000 shares of common stock and/or 375,000 warrants to cover over-allotments, if any. The company intends to use the net proceeds for its Phase 2 trial for Berubicin, other research and development, as well as for working capital. Subject to customary conditions, the offering is expected to close on or about Dec. 28, 2020. A.G.P./Alliance Global Partners is acting as the sole book-running manager for the offering.

To view the full press release, visit http://ibn.fm/Jo8Cf

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. For more information, visit the company’s website at www.CNSPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at http://ibn.fm/CNSP

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, December 23rd, 2020 Uncategorized Comments Off on $CNSP Announces Pricing of $10M Public Offering

$DRIO Researchers Disinfect Face Masks Using Industrial Microwaves

Cardiff University researchers have been conducting tests to see whether it is feasible to sterilize personal protective equipment (PPE) used by health practitioners to combat the COVID-19 pandemic using dry heat and microwave ovens. The researchers’ findings were published in the “Journal of Hospital Infection.

The group of researchers demonstrated that some respirators could be sterilized successfully in one and a half minutes using a baby bottle sterilizer that had water and an industrial-grade microwave oven.

Jean-Yves Maillard, a professor from Cardiff’s School of Pharmacy and Pharmaceutical Sciences who is also the study’s co-author, explained that the inability of frontline workers to access enough PPE puts both them and the patients they take care of at risk of getting the coronavirus. The researchers’ aim was to find out whether single-use masks could be used again after being safely decontaminated.

The scientists believe that decontaminating masks using a microwave could be used in emergency situations to increase the respirators available to frontline workers while also addressing any issues encountered with regard to supply.

During the study, the team introduced respirators and ran them through three microwave decontamination cycles. They discovered that the respirators reserved their capacitiea to filter viral-sized aerosols and other bacteria. However, the researchers also discovered that when surgical masks were microwaved, they lost their ability to filter aerosols.

Another co-author of the study, Michael Pascoe, also from the School of Pharmacy and Pharmaceutical Sciences, explained that surgical masks usually lose their efficacy when they get moist. The researchers supposed that disinfecting the masks using a microwave would cause a loss in their filtration capacity, which was established by the observations made in the lab.

The group of researchers, which also comprised School of Engineering academics, looked into the use of dry heat ovens as another sterilization method. Sterilization using dry heat does not require water, which makes it compatible with articles that can be damaged by moisture.

The researchers discovered that exposing respirators and surgical masks to dry heat at 70 degrees Celsius for one and a half hours effectively disinfected both PPEs. Additionally, both surgical masks and respirators maintained their ability to filter aerosols after three cycles of dry heat.

It should be noted that the researchers would not recommend using this method at home. School of Engineering’s Professor Adrian Porch explained that this is because domestic microwave ovens use rotating turntables and have a significantly lower power. So in order to achieve similar results, one would need to expose the protective equipment for a much longer period. Masks also have thin wires, which can catch fire when put in microwaves. In addition, researchers are not certain how this method of sterilization would impact the masks’ efficacy and functioning.

Aside from the coronavirus and face masks, many firms are hard at work seeking remedies to various health conditions. For instance, DarioHealth Corp. (NASDAQ: DRIO) shines as a provider of smartphone-based technologies which help those with chronic diseases to make durable lifestyle changes.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, December 23rd, 2020 Uncategorized Comments Off on $DRIO Researchers Disinfect Face Masks Using Industrial Microwaves

Cybin Inc. (NEO: CYBN) Researchers Develop Synthetic Ibogaine to Treat Depression, Addiction

Ibogaine is a psychoactive substance that triggers hallucinations; the substance is found in the Apocynaceae family of plants. Ibogaine has been used in spiritual ceremonies by the Bwiti tribe of Gabon for centuries. However, it wasn’t until the ’50s that ibogaine became popular in the West as a treatment for depression and addiction.

Despite this rising popularity, however, ibogaine isn’t a medicine per se as it may lead to heart attacks and it’s illegal in most countries. Still, it was used by researchers recently to develop a non-hallucinogenic, non-toxic chemical cousin that helps tackle addictive and depressive behaviors in rodents. This innovative treatment provides hope that in the future chemists may develop medicines for individuals that offer the therapeutic benefits of other psychoactive compounds including ibogaine, tailored to exclude potential side effects.

Many psychedelics, including psilocybin, ibogaine and LSD, have long been perceived as potentially effective treatments of depression and addiction. Apart from possessing a mechanism of action different from the psychiatric medicines currently in use, psychoactives also give rise to long-lasting effects after a few doses have been administered, which suggests that they may not only be efficacious but they may also treat more people.

Individuals who suffer from addiction and depression usually lose some of their prefrontal cortex’s synaptic connections. The prefrontal cortex in the brain is connected to social behavior, personality and decision-making. Ketamine and LSD are psychoactive compounds that have been shown to help with addiction and depression in some individuals. The two psychedelic compounds appear to help the neurons in the prefrontal cortex communicate better through encouraging dendritic spine growth.

David Olson, a chemical neuroscientist from the University of California, led researchers in a study that discovered tabernanthalog, a non-hallucinogen derived from ibogaine. The group of researchers synthesized 20 chemical analogs of ibogaine and discovered TBG, or tabernanthalog, to be the most promising compound that was free from hallucinogens and toxic substances. They tested the compound on rodents and noticed that it supported dendritic spine growth in both the rodents and in cells. One injection of TBG was found to protect an individual against a heroin use relapse for two weeks. The team published its research in the “Nature” journal, explaining that the compound did not lead to dependency because it did not stimulate the reward centers of the brain.

Additionally, the researchers noted that TBG binds to serotonin receptors, which are also targeted by psilocybin and LSD, suggesting that the compound provides its beneficial effects without causing hallucinations.

A number of companies have shown interest in the psychedelic space. A clear example is Canadian-based Cybin Inc. (NEO: CYBN), which is engaged in developing psychedelic medicines as well as functional mushroom products.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Wednesday, December 23rd, 2020 Uncategorized Comments Off on Cybin Inc. (NEO: CYBN) Researchers Develop Synthetic Ibogaine to Treat Depression, Addiction

$CRTD Provides Update on Proprietary Platform Performance in 2020

Creatd (NASDAQ: CRTD), the parent company of Vocal, has released a year-in-review overview for the proprietary technology platform. The update spotlights the creators, stories and milestones that distinguished the platform throughout 2020. In addition, the update notes how Vocal supported the creative community, helping it survive during a year that faced major challenges presented by the global pandemic. The update reported that Vocal creators submitted more than 120,000 stories while users spent an average of more than four minutes consuming those stories. In addition, Vocal creators received more than $400,000 in revenue throughout the year; $195,000 of that was earned through exclusive Vocal challenges. “It is important in today’s business environment for investors to acknowledge and understand that in order to build a valuable company, our management team and, more importantly, the platform must be contributing to more than just the bottom line,” said Creatd CEO and founder Jeremy Frommer. “As I have always said, and as our Year in Review confirms, when our creators succeed, the company succeeds.”

To view the full press release, visit http://ibn.fm/KzN0G

About Creatd Inc.

Creatd empowers creators, brands, and entrepreneurs through technology and partnership. Its flagship technology, Vocal, is a best-in-class creator platform. For more information about the company, please visit www.Creatd.com.

NOTE TO INVESTORS: The latest news and updates relating to CRTD are available in the company’s newsroom at http://ibn.fm/CRTD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, December 23rd, 2020 Uncategorized Comments Off on $CRTD Provides Update on Proprietary Platform Performance in 2020

$RACMF Building on NCAA COVID ‘Bubble’ Success with Plans for Virus-free Film, Travel Bubbles

December 23, 2020

Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) Building on NCAA COVID ‘Bubble’ Success with Plans for Virus-free Film, Travel Bubbles

  • Loop Insights is an innovative data technology solutions provider developing contactless, digital wallet-based marketing, tracing and notification services
  • During the COVID era, Loop’s venue management solution serves as a companion to contactless ticketing, and testing allowing attendees to receive alerts and notifications as well as proof of testing or vaccination and event / venue managers to monitor the same risk and deliver venue tracing alerts directly integrated with rapid testing.
  • Following on the heels of the NBA’s massive COVID-free protective “bubble” experiment for the pro basketball season and playoffs, Loop served as the tech resource for two NCAA bubble events and successfully provided organizers the data they needed
  • Loop is now partnering with rapid COVID test supplier Empower Clinics and aviation marketing consulting firm SimpliFlying to provide an international travel virus-protection bubble program, as well as a film industry bubble
  • Loop intends to uplist from its TSX.V position to the broader TSX exchange, and then if successful to file with the Securities and Exchange Commission (“SEC”) in the United States to list on the NASDAQ

During the final weeks of 2020, the medical community has begun to experience real optimism in pushing back against the novel coronavirus pandemic that has sickened nearly 75 million people worldwide as of a week before Christmas, taking the lives of more than 1.6 million, and leaving some 20.5 million still in the throes of the illness with the Christmas holiday rapidly approaching (https://ibn.fm/MDktc).

With the rollout of one vaccine believed to be safe and effective in combating COVID-19 happening now, and additional vaccine approvals expected in the near future (https://ibn.fm/1Ivo8), business industry leaders are also tentatively beginning to adopt event and venue “bubble” practices that allow them to resume in-person, revenue-building activities while attempting to prevent infected people from attending. Bubble planning includes efficiently identifying any potential breach of the event / venue infection security net so that organizers can effectively provide contact-tracing warnings to participants who may have been exposed, as addressed in a report by event news outlet EventMB (https://ibn.fm/xRyvx).

Vancouver-headquartered Loop Insights (TSX.V: MTRX) (OTCQB: RACMF) is dedicating much of its focus on Internet of Things (“IoT”)-based contactless solutions to enabling renewed event / venue activity. The company has already successfully provided end-to-end venue tracing and alert notifications for two NCAA Division 1 basketball events and is expanding on its successes with bubble planning in non-sports markets such as the film and travel industries, as well as new sports events in 2021.

“There is simply no way to overstate the implications of our live environment Venue Bubble successes in Florida and Las Vegas over the past 10 days,” Loop Insights CEO Rob Anson stated about the NCAA events (https://ibn.fm/aLSVV). “With the whole world watching, including professional sports leagues and teams, college sports leagues and teams, world-renown venues and hospitality companies, Loop hit it out of the park and provided the world with the empirical data necessary to demonstrate our bubble solution is nothing short of world-class.”

The professional NBA basketball league set the initial standard for sports-related virus bubbles, creating a $190 million isolation zone at Florida’s Walt Disney World during the final eight games of the 2019–20 regular season and throughout the playoffs. The bubble was enacted in six phases between June and October, and no cases of COVID-19 were recorded by the teams participating in the bubble (https://ibn.fm/AUrR6).

Loop Insights’ IoT contactless venue management solution deployed in the NCAA events includes using smart wallet pass technology to manage tracing, testing, notifications and marketing. Attendees enter their personal information upon arrival, including their name and how to contact them, without having to rely on the exchange of hand written forms. The mobile wallets are used to authenticate the attendees’ information and to allow the exchange of information between the event / venue managers and the attendees regarding the data the venue requires, as explained in an October Loop webcast demonstrating the platform’s performance (https://ibn.fm/Q0feV).

The company’s recently announced expansion into virus-free bubble projects for the film industry (https://ibn.fm/dNvjQ) and the travel industry include a standout partnership with medical testing innovator Empower Clinics (CSE: CBDT) (OTC: EPWCF) (FRA: 8EC) and an MOU with aviation marketing consulting firm SimpliFlying to create an international airline travel bubble solution (https://ibn.fm/dFXHB).

Empower’s rapid antigen and antibody tests produce results in 15 minutes, providing the potential for a sense of security during the pandemic to airlines, cruise ships and the 182 countries currently in full or partial shutdown (https://ibn.fm/zpE9Q). The partners’ travel bubble product is now advancing talks for an agreement with the national tourism boards of the Dominican Republic, the Cayman Islands, the Bahamas, Jamaica and the Turks & Caicos islands, as well as the Iberostar, Bahia Principe and Hyatt Resorts, according to the company’s announcement.

Loop also recently announced its digital wallet and venue platform will support English, French and Spanish initially — a capability considered necessary as part of the partnership’s pursuit of nationwide agreements, particularly as Canada considers a unified solution with tracing, testing, and vaccination certification (https://ibn.fm/vAIfc).

The announcement includes notice that the company received $4.6 million from the exercise of warrants up to Dec. 10, which eliminates the need for any financing with the exception of strategic client partners that may want to invest in Loop in order to participate in its growth. Loop currently lists on the TSX.V and intends to uplist to the broader TSX exchange to increase its investment potential. If the TSX uplisting is successful, the company will eventually pursue filings with the Securities and Exchange Commission (“SEC”) in the United States to potentially list on the NASDAQ (https://ibn.fm/EZcxq).

For more information, visit the company’s website at www.LoopInsights.ai

NOTE TO INVESTORS: The latest news and updates relating to RACMF are available in the company’s newsroom at https://ibn.fm/RACMF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, December 23rd, 2020 Uncategorized Comments Off on $RACMF Building on NCAA COVID ‘Bubble’ Success with Plans for Virus-free Film, Travel Bubbles

$VTGN Closes $100M Underwritten Public Offering

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, has announced the closing of its $100 million underwritten public offering. The offering consisted of 63,000,000 shares of its common stock at an offering price of $0.92 per share, par value $0.001 per share, and 2,000,000 shares of its Series D convertible preferred stock at a public offering price of $21.16 per share. All of the securities in the offering were sold by VistaGen. Acuta Capital, New Enterprise Associates (“NEA”), OrbiMed and Venrock Healthcare Capital Partners, among others, participated in the offering as lead investors. VistaGen intends to use the net proceeds for research, development and manufacturing and regulatory expenses associated with continuing development of PH94B, PH10, AV-101, and potential drug candidates to expand its CNS pipeline and for other working capital and general corporate purposes. Jefferies LLC and William Blair & Company, L.L.C. acted as joint book-running managers for the offering and Maxim Group LLC acted as a financial advisor.

To view the full press release, visit: https://ibn.fm/3ORhO

About VistaGen Therapeutics Inc.

VistaGen is a biopharmaceutical company committed to developing and commercializing innovative medicines with potential to go beyond the current standard of care for anxiety, depression and other CNS disorders. Each of VistaGen’s three drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date and has therapeutic potential in multiple CNS markets. For more information, please visit www.VistaGen.com and connect with VistaGen on TwitterLinkedIn and Facebook.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at http://ibn.fm/VTGN

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, December 23rd, 2020 Uncategorized Comments Off on $VTGN Closes $100M Underwritten Public Offering

$WTER 420 with CNW – Factors to Keep in Mind Before Starting a Marijuana Dispensary

If you have plans to start a business that deals with hemp products or cannabis, you should first look into the limitations, processes and rules involved. The business may have a promising future as various states in the United States have legalized the use of marijuana, with many hoping that others follow suit.

In addition to ensuring that you have obtained the permits and licenses required, there are a few more factors that you should consider before beginning a marijuana dispensary.

Regulations and rules

If you are planning to start your business in the United States, you should note that some states have strict restrictions on the use of cannabis. If you’re operating outside the U.S., you’ll find that many nations have legalized the consumption of cannabis, but many have specific regulations in place as well. Therefore, when it comes to the quantities and constituents of your products, ensure that no limits are crossed. This also means that you should acquire the required permits and licenses necessary to operate a dispensary in your area. This will help prevent your business or you from any legal dangers. Ensure that you do your research based on your area of operation.

Select your products carefully

It is important to be knowledgeable on the specific variations and types of products that you plan to sell before opening a dispensary. Various varieties of hemp and marijuana strains are available on the market. Each hemp and marijuana strain may produce different effects in consumers after consumption. To give provide the intended effects, you should select the right strains. Additionally, highg-quality products go a long way, so never compromise on quality.

Your business type

Different types of businesses exist in the marijuana industry. Some may have you play the role of a retail provider of marijuana products and strains while others may have you growing new marijuana strains and selling them. Make sure that you file your business as the proper entity as described by the state. How you register your business may affect the taxation and operation policies, so take note.

In addition to the factors mentioned above, how you market your business and the reputation of your business are both important. Make certain that you promote your services, especially on social media to help increase foot traffic in your store.

Maintaining and cultivating trust among your consumers is important for the reputation of your business. This can be done by selling high-quality cannabis or hemp products that produce the expected results. Being available to answer any questions your consumers may have concerning various products will be good for the business as well.

Many companies that have found their niche are performing well in the cannabis market. For example, The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) added a line of CBD-infused topical products and edibles to its premium bottled alkaline water.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Wednesday, December 23rd, 2020 Uncategorized Comments Off on $WTER 420 with CNW – Factors to Keep in Mind Before Starting a Marijuana Dispensary

$SGTM Offers Relatively Stable Investment Opportunity in Ethical – and Profitable – Company

December 23, 2020

Sustainable Green Team Ltd. (SGTM) Offers Relatively Stable Investment Opportunity in Ethical – and Profitable – Company

  • Recent interview on CNBC featured prominent analyst advising investors against “egregiously expensive” tech stocks
  • SGTM is profitable company that transforms natural waste into organic gardening products, playground surface material
  • Recent financial results include Q3 revenue of $5.9 million, 4,817% increase in gross profit during first half of 2020 when compared to all of 2019
  • Clients include The Kroger Co., Circle K, 7-Eleven, Menards Inc. and Old Castle Lawn & Garden

COVID-19 has sent the global economy into a tailspin, forcing the closure of hundreds of thousands of businesses along with the loss of millions of jobs. The stock market, however, appears to have decoupled from reality as it sets record highs amid this global economic catastrophe (https://ibn.fm/JcHkb). Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, is a small but bright light among thousands of overvalued stocks, offering investors an opportunity to invest in an ethical, sustainable and profitable company.

MBMG Group Managing Director Paul Gambles recently gave an interview on CNBC advising investors to avoid “scarily priced” IT and consumer discretionary stocks, claiming that such investments were “egregiously expensive” (https://ibn.fm/t7WmY). Citing recent statistics from the MSCI World Consumer Discretionary Price Index and the MS World Information Technology Price Index – both of which have shot up by 85% and 75% respectively since last March – Gambles suggested that these types of stocks had benefited from shifts into digital and e-commerce amid COVID-19, but noted that the trend would not last much longer.

While momentum stocks in the S&P 500 have risen 28% so far this year, high-quality investments in discretionary stocks characterized by high dividends and low volatility have actually fallen. Adding to the confusion is the fact that most well-known tech “giants” such as Uber, Spotify and Airbnb have never actually turned a profit (https://ibn.fm/zrIAs). The resulting situation is creating confusion among investors and analysts struggling to make sense of a market that appears to be largely driven by investor speculation.

While SGTM does not have a digital platform, app, or plans to launch satellites into space, it does offer an opportunity to invest in a profitable company that takes sustainability seriously. Through its subsidiaries and partners, SGTM collects tree debris caused by storms and hurricanes and transforms it into environmentally friendly gardening mulch products and certified organic playground surfacing material.

Mulch is a multi-million dollar business that provides benefits to the earth, including natural weed control, temperature regulation, moisture retention and soil erosion prevention. Rather than allow tree debris to burden landfills, SGTM transforms it into a valuable product that is sold nationwide through contracts with corporate giants like The Kroger Co., Circle K, 7-Eleven, Menards Inc. and Old Castle Lawn & Garden.

Unlike many tech stocks making headlines in the financial markets, SGTM actually turns a profit. Besides growing significantly in 2020, the company recently reported $5.9 million in Q3 revenue (https://ibn.fm/H1s7t) along with an impressive 4,817% increase in gross profit during the first half of 2020 when compared to all of 2019 (https://ibn.fm/s6O8t). With plans to uplist to NASDAQ in the near future, the company has completed a 2-year audit and commenced its FORM-10 process to become fully reporting.

In an investment environment rife with volatility and speculation, SGTM offers synergistic solutions that benefit the environment while offering investors an excellent opportunity to purchase shares in a sustainable business. The company is committed to continue driving forward its mission while meeting the increasing demand for sustainable solutions to serious environmental issues.

To learn more about Sustainable Green Team Ltd., view the investor presentation at https://ibn.fm/EBY3V.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, December 23rd, 2020 Uncategorized Comments Off on $SGTM Offers Relatively Stable Investment Opportunity in Ethical – and Profitable – Company

$POAI Integrates Data, AI to Pave Path for Better Health Outcomes

Predictive Oncology (NASDAQ: POAI), a knowledge-driven precision medicine company focused on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery, is positioned to play a critical role in the precision oncology industry. The company integrates AI technology with oncologists’ clinical decision-making processes, paving the way for improved health outcomes. A recent article discussing this reads, “POAI is focused on the use of data and artificial intelligence to develop personalized cancer therapies through its trove of valuable assets, including a database of clinically validated historical and outcome data from patient tumors, an in-house Clinical Laboratory Improvement Amendments (‘CLIA’)-certified lab, a ‘smart’ patient-derived tumor profiling platform, an in-house bioinformatics artificial intelligence platform, and a proprietary approach to growing tumors in the lab to rapidly develop patient-specific treatment options.”

To view the full article, visit: https://ibn.fm/GyjPp

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, December 23rd, 2020 Uncategorized Comments Off on $POAI Integrates Data, AI to Pave Path for Better Health Outcomes

$ICLK Confirms Resolution in Annual General Meeting

iClick Interactive Asia Group Limited (NASDAQ: ICLK), a China-based company, has shared the results of its annual shareholder general meeting; the meeting was held Dec. 23, 2020, in Hong Kong. During the meeting, iClick shareholders approved and ratified the appointment of a new director. Subsequent to the meeting, it was announced that Matthew Chu Pong Fong had been ratified as a director of the independent online marketing and enterprise data solutions provider. iClick is committed to connecting worldwide marketers with potential target audiences located in China, the largest country in the world by population and the fourth largest country in the world by geography. The company has a worldwide presence, with 10 operating locations scattered globally, including in Asia and Europe.

To view the full press release, visit http://ibn.fm/YhM6P

About iClick Interactive Asia Group Limited

iClick Interactive is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, the company’s proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in 10 locations worldwide including Asia and Europe. For more information about the company, please visit www.iClick.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, December 23rd, 2020 Uncategorized Comments Off on $ICLK Confirms Resolution in Annual General Meeting

$GNPX Enters into Estimated $12-Million Securities Purchase Agreement

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has entered into a securities purchase agreement with a single healthcare-dedicated institutional investor. The agreement outlines the purchase and sale of 3,116,884 shares of Genprex common stock; the purchase price of those shares will be $3.85 per share in a registered direct offering priced at-the-market under Nasdaq rules. The agreement, which is expected to close on or before Dec. 24, 2020, also stipulates that no warrants will be issued in connection with the transaction. The offering closing is subject to the satisfaction of customary closing conditions. Sole placement agent for the offering is A.G.P./Alliance Global Partners. Interested parties are encouraged to read all the information regarding the offering; all required and pertinent information has been filed with and is available from the U.S. Securities and Exchange Commission (“SEC”).

To view the full press release, visit http://ibn.fm/sNz3D

About Genprex Inc.

Genprex is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company’s lead product candidate, GPX-001 (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). GPX-001 has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. GPX-001 has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted fast track designation for GPX-001 for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with “EFGR” mutations whose tumors progressed after treatment with osimertinib alone. For more information, please visit the company’s website at www.Genprex.com

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, December 23rd, 2020 Uncategorized Comments Off on $GNPX Enters into Estimated $12-Million Securities Purchase Agreement

$UUUU Industry Experts Advise Mining Firms to Transform, Innovate – or Be Left Behind

IntelliSense.io recently had an event that centered on a discussion around mining processes and technology and the future of mining. The session included BHP’s head of innovation Cleve Lightfoot, senior VP of Oilfield & Mining solutions Damien Caby; Ippei Akiyoshi of the CVC Mineral Resources Group; and Sam G Bose, CEO and founder of IntelliSense.io.

The themes discussed during the forum focused on why the mining industry requires change, what the industry would look like in the future and how the industry could adopt innovation. At the center of this discussion was the view that mining processes and technology were out of date.

Lightfoot expounded on this, stating that the industry was working with processes and technology that were developed nearly a century ago, which makes those processed and technology unsuitable for the future of the mining industry. He added that while the technology was more efficient as well as bigger and better, the industry had not taken into account how operations in the mining industry had changed and the fact that it would continue changing at a more rapid pace.

Bose said that sustainability solutions had become an immediate need for the mining industry as advanced technologies were developed. He stated that the next-generation miners were more vocal on this change as it would enable mining to occur in a way that was more sustainable. Additionally, he added that new miners entering the industry were looking into various systems that would allow them to access information instantaneously, which would allow them to make decisions using data in real time. This, he said, had also acted as an incentive for the industry to explore alternative ways of operation.

Akiyoshi of Mitsubishi supported this view, adding that investors were also keenly interested in the environmental consciousness of mining firms. He stated that developing a good economic value was good but that mining firms needed to demonstrate that they not only cared for the environment but were also responsible in how they carried out their operations.

Caby from BASF chimed in, stating that from an operational viewpoint, the demand for material that was environmentally-conscious and ethically sourced had also influenced the direction of the natural resource industry significantly. He explained that this was the largest driver of change as it would shift the way most minerals would be extracted from the earth.

He then suggested that moving forward, companies would need to prioritize their opportunities, which would include understanding the situations of their own mines and unlocking their operational data value before they began their innovation journey.

Speaking of technological transformation, Energy Fuels Inc. (TSX: EFR) (NYSE American: UUUU) has three facilities at which it leverages two key technologies —in-situ recovery and conventional extraction methods — to excel at mining uranium.

About MiningNewsWire 

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Wednesday, December 23rd, 2020 Uncategorized Comments Off on $UUUU Industry Experts Advise Mining Firms to Transform, Innovate – or Be Left Behind

$WRAP Secures Growing Number of New, Repeat Domestic and International Orders

Wrap Technologies (NASDAQ: WRAP), an innovator of modern policing solutions, today announced international reorders and a growing number of new and repeat domestic orders for BolaWrap(R) products and accessories. According to the update, WRAP recently received several international reorders totaling over 600 BolaWrap devices, plus cartridges and accessories. The company also received over 50 new orders and more than 15 reorders for domestic law enforcement agencies over the last thirty days. “Despite the social, political, financial and health care challenges seen by law enforcement in 2020, we are proud of the commitment our partner agencies are making to increase public safety and safely de-escalate potentially higher levels of force,” said Tom Smith, president and interim CEO of WRAP Technologies. “We are seeing increases in both agency adoption and successful field deployments, signaling what we believe is part of a changing tide in the way law enforcement approaches non-compliant but non-violent subjects.”

To view the full press release, visit https://ibn.fm/8jptl

About Wrap Technologies Inc.

Wrap Technologies is an innovator of modern policing solutions. The company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R) tether to restrain an individual at a range of 10-25 feet. Developed by award winning inventor Elwood Norris, the company’s chief technology officer, the small but powerful BolaWrap 100 assists law enforcement to safely and effectively control encounters, especially those involving an individual experiencing a mental crisis. BolaWrap 100 has already been used to safely apprehend suspects without injury in a number of cities including Los Angeles, Sacramento, Fresno, Bell, Albuquerque, Minneapolis, West Palm Beach, Fort Worth, and Oak Ridge. For information about the company, please visit www.WRAP.com.

NOTE TO INVESTORS: The latest news and updates relating to WRAP are available in the company’s newsroom at http://ibn.fm/WRAP

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, December 21st, 2020 Uncategorized Comments Off on $WRAP Secures Growing Number of New, Repeat Domestic and International Orders

$WTER 420 with CNW – Cannabis Possession Decriminalized in Northern Ireland

Individuals who are caught with marijuana for personal use in Northern Ireland will not be prosecuted or have a criminal record and will instead be dealt with under the adult-caution system, which was established more than a decade ago. However, this only applies to individuals who haven’t been caught repeatedly with personal-use marijuana or people who have not been caught with bigger marijuana shipments.

Among the four new offenses added to the adult-caution scheme include the possession of personal-use cannabis. The objective of this is to free up resources of the court and Garda, the national police force, while dealing with offenders in a more informal setting. This is a pioneer moment given that this will be the first time that an illicit drug’s offense will be dealt with using a prosecution-based process instead of through the conventional criminal justice system.

The purpose of the adult-caution scheme is to eliminate the threat of a criminal record for individuals who are first-time offenders or those who have committed offenses that can be considered as relatively minor. Garda Headquarters, located in Phoenix Park, recently stated that possession of personal-use marijuana had been included in the adult-caution scheme just days ago.

Following an agreement with the director of public prosecutions, a couple of other offenses were included as well, including the breaching the control-of-access-to-certain-events clause found in the Public Order Act. Trespassing in a manner that may give rise to fear or casual trading contrary to one’s license terms or without a license were also added to the caution scheme.

Last year, the minister of health at the time, Simon Harris, announced the state’s plans to add possession of herbal marijuana or marijuana resin to the adult-caution scheme, highlighting that this move would affect nearly 12,000 individuals annually who are caught by the Garda for possession of drugs for personal use. He explained that instead of being processed under the criminal justice system, roughly 10% of these cases would be referred for therapy and further treatment under the new system.

However, in the drug policy report that was released at around the same time, a Garda Síochána declared that they were against multiple adult cautions, arguing that illicit drug users could exploit the new scheme. The Garda observation stated that couriers and drug dealers alike may begin carrying drugs in small quantities, with the knowledge that they are allowed to possess a quantity of drugs for personal use.

Some companies in North America have opted to make products that are fall within the laws governing cannabis. For example, The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) has added a collection of CBD-infused edibles and topicals to its line of products.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Monday, December 21st, 2020 Uncategorized Comments Off on $WTER 420 with CNW – Cannabis Possession Decriminalized in Northern Ireland

$SGTM Provides Sustainable Solution to Storm Recovery Efforts in Burgeoning Industry

December 21, 2020

Sustainable Green Team Ltd. (SGTM) Provides Sustainable Solution to Storm Recovery Efforts in Burgeoning Industry

  • SGTM brings environmentally friendly, sustainable approach to tree and storm waste disposal
  • Company processes its tree debris into variety of organic mulch products, was recently awarded contracts to market its products through The Kroger Co., Circle K stores
  • SGTM recently awarded IPEMA certification to commence recycling waste into playground surfacing material sector, which is expected to be valued at over $5.8 billion by 2026
  • Active 2020 hurricane season has led to increased demand for SGTM’s storm, tree recovery services

Sustainable Green Team (OTC: SGTM) has historically sought to provide a synergistic and environmentally beneficial solution to tree and storm waste disposal, helping to alleviate the environmental burdens which have traditionally afflicted landfills and disposal sites around the country. Accordingly, throughout its 40-year corporate tenure, SGTM has prided itself in building a reputation as an environmentally responsible enterprise, focused on being “stewards of the environment” across all aspects of its business.

Sustainable Green Team’s vertically integrated operations have been founded around the central tenet of sustainability—a trait which has been prevalent across all facets of its operations. Following the collection of tree debris through its tree services division and collection sites, the company subsequently transfers the amassed tree biomass through to the processing divisions for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products, which are then packaged and sold to retailers, landscapers and for general agricultural purposes.

SGTM has found a willing audience for its products, revealing recently that its subsidiary, Mulch Manufacturing Inc., had been awarded contracts to supply The Kroger Co. and Alimentation Couch-Tard’s Circle K subsidiary with premium grade organic mulch products over the coming year (https://ibn.fm/0AJnV).

“We have been blessed to be offered these amazing opportunities from large chain accounts to help further expand our brand and overall exposure,” stated SGTM CEO and Director Tony Raynor (https://ibn.fm/OctuN).

In addition to its efforts in recycling tree and storm waste into commercialized mulch products, the Sustainable Green Team has recently gained the International Play Equipment Manufacturers Association (“IPEMA”) certification to commence recycling waste into playground surfacing material. With a growing demand for playground surfacing material from schools, commercial athletic facilities and recreational spaces, SGTM’s new product line is expected to help the company tap into a market estimated to rise to a value of over $5.8 billion by the end of 2026, a 150% increase from 2017’s $3.7 billion (https://ibn.fm/vqDhT).

The 2020 Atlantic hurricane season was destined for the record books before it even started. Meteorologists began calling for an above-average storm season as early as December 2019 (https://ibn.fm/WzeZ7), with predictions of 15-20 named storms and four major hurricanes. However, eclipsing initial forecasts, the Atlantic hurricane season has thus far been comprised of 30 tropical storms, 13 hurricanes and six major hurricanes with initial assessments estimating the cumulative economic impact of the storms at an estimated $38 billion (https://ibn.fm/3LjQT).

The active storm season has led to a commensurate increase in the demand for tree recovery/collection services which has translated into greater sales for the company’s end products.

“Getting paid for your feedstock in the mulch business is a recipe for success and great profit margins,” said Raynor. “Storm recovery is a multibillion-dollar business, and we are prepared to help in any cleanup process.”

To learn more about Sustainable Green Team Ltd., view the investor presentation at https://ibn.fm/EBY3V.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, December 21st, 2020 Uncategorized Comments Off on $SGTM Provides Sustainable Solution to Storm Recovery Efforts in Burgeoning Industry

$PCSA FDA Approves OTC Coronavirus Home-Sample Collection Kit

Last week, the Food and Drug Administration (FDA) announced that it had approved the first over-the-counter (OTC) home-sample collection kit for the coronavirus. The coronavirus test collection kit — LabCorp Pixel kit — is permitted for use by people aged 18 years and above and can be used without a prescription. The testing kit includes a nasal swab, which will be used to collect a sample at home. The self-collected sample can then be sent out to be tested at LabCorp.

Test users will then receive their test results either through an online portal, a phone call from their health-care provider or email. If test results are negative, they will be delivered through the user online portal or via email. However, if an individual’s test results are invalid or positive, the results will be delivered to the individual via a phone call from a health=care provider.

Using this home-sample collection kit eliminates the need to leave your house to get tested, which exposes an individual to various risk factors. The FDA states that the home-collection kit allows its users to learn more about their coronavirus infection status, which could help in determining whether quarantining oneself would be an appropriate measure. The kit would also assist an individual’s health-care professional to make the appropriate decision concerning their patient or give proper advice on measures to be taken.

In another news release by the FDA, Jeff Shuren, the director of the Center for Devices and Radiological Health, explained that currently several home-collection kits are available for prescription using an online questionnaire. However, the newly approved home-sample collection kit makes it easier for individuals to obtain samples and send those samples to a lab for processing, without having to fill out a questionnaire and await a prescription.

Earlier this month, the FDA also reported that an at-home diagnostic test that could be used to collect samples of influenza B and A as well as the coronavirus had been approved. The Quest Diagnostics Self-Collection Kit for the flu and coronavirus and the Quest Diagnostics Flu and coronavirus reverse transcription PCR test can be used by individuals who suspect that they may have a respiratory viral infection with the coronavirus; both are available to the public and can be obtained using a prescription.

Aside from COVID-19, many biopharm companies are working to develop remedies for various ailments afflicting people. An example is Processa Pharmaceuticals Inc. (NASDAQ: PCSA), a company that focuses on acquiring drugs still in the development stage but with reasonable evidence of efficacy.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Monday, December 21st, 2020 Uncategorized Comments Off on $PCSA FDA Approves OTC Coronavirus Home-Sample Collection Kit

$PBIO Life Sciences Company Investor Presentations Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations

NEW YORK, Dec. 21, 2020 — Life Sciences Investor Forum today announced that the presentations from the December 17th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.

This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”.

REGISTER OR LOGIN AT: https://bit.ly/2Wqsir2

December 17 th Presenting Companies:

Company Name Ticker(s)
Kane Biotech Inc. OTCQB: KNBIF | TSX-V: KNE
Theralase Technologies Inc. OTCQB: TLTFF | TSX-V: TLT
Caladrius Biosciences, Inc. NASDAQ: CLBS
Pressure BioSciences, Inc. OTCQB: PBIO
HLS Therapeutics Inc. TSX: HLS
Bionexus Gene Lab Corp. OTCQB: BGLC
VolitionRx Limited NYSE AMERICAN: VNRX
XPhyto Therapeutics Corp. OTCQB: XPHYF | CSE: XPHY | FSE: 4XT
Avicanna Inc. OTCQX: AVCNF | TSX: AVCN

To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com .

About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

CONTACT
Life Sciences Investor Forum
John M. Viglotti
SVP Corporate Services, Investor Access
(212) 220-2221
johnv@lifesciencesinvestorforum.com

Monday, December 21st, 2020 Uncategorized Comments Off on $PBIO Life Sciences Company Investor Presentations Now Available for On-Demand Viewing

$POAI Adjourns Special Virtual Meeting; CEO Requesting Shareholder Vote for Critical Tax-Related Proposal

  • POAI sent letter to shareholders requesting attendance at virtual Special Meeting on December 30, 2020
  • Meeting will address reincorporation of POAI in Nevada
  • Reincorporation expected to save POAI approximately $158,000 annually in state taxes
  • Shareholders can vote online or by telephone, detailed instructions outlined in proxy materials

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently sent a letter to all shareholders urging them to attend a virtual Special Meeting of Stockholders (the “Meeting”). Originally scheduled for December 1, 2020, the Meeting will be reconvened on December 30, 2020 at 3:00 p.m. CST, where all shareholders will be requested by the Board of Directors and management of POAI to vote “FOR” the proposals put forward at the Meeting.

The Board of Directors and management of POAI are proposing that the corporation reincorporates in Nevada for the purpose of eliminating its obligation to pay the Delaware franchise tax of approximately $170,000 per year. By reincorporating in Nevada, POAI management believes that the company can save approximately $158,000 annually in state taxes.

“We are asking you to vote for allowing the company to reincorporate in the state of Nevada, moving away from Delaware,” writes POAI CEO Carl Schwartz (https://ibn.fm/UsMtz).  “First and foremost, the reincorporation in Nevada will eliminate our obligation to pay the injurious annual Delaware franchise tax, which is currently equal to approximately $170,000 per year. We can save approximately $158,000 annually in state taxes by reincorporating in Nevada. Also, we believe that for the reasons described in the proxy materials, in general, Nevada law provides greater protection to our directors, officers and the company than Delaware law.”

In order for the reincorporation to be approved, the proposal must receive a “For” vote from the majority of outstanding shares of common stock of the company. At POAI’s recent Annual Meeting, the reincorporation vote received a larger amount of “For” votes than “Against” votes; however, the amount required for the vote to pass fell short for a majority of the outstanding shares. Management at POAI is urging all shareholders to vote their shares online or by telephone by following the instructions outlined in their proxy materials.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow.

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Monday, December 21st, 2020 Uncategorized Comments Off on $POAI Adjourns Special Virtual Meeting; CEO Requesting Shareholder Vote for Critical Tax-Related Proposal

$UUUU Announces Publication of Sustainability Report, Policy Updates

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company, today announced it has published its Sustainability Report, along with its Climate Change Policy, Human Rights Policy and Vendor Code of Conduct. According to the update, these, together with its other policies, describe the company’s ongoing commitment to the environment, worker health, public safety and social responsibility, including its important role in combating global climate change through producing and recycling carbon-free energy resources. Each of these documents is publicly available on the Energy Fuels website. “Energy Fuels might be the best untold clean energy and sustainability story in the U.S. today. We believe our recently published Sustainability Report tells this story, along with our commitments to human rights and corporate and social responsibility,” said Mark S. Chalmers, president and CEO of Energy Fuels. “We are proud of the growing roles we play in helping address global climate change, reducing air pollution, making clean energy technologies possible, and working to make the world a healthier and cleaner place.”

To view the full press release, visit http://ibn.fm/pVNf0

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant, and anticipates commencing commercial production of rare earth element (“REE”) carbonate in 2021. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, has the ability to produce vanadium when market conditions warrant and is completing final test-work for the production of REE carbonate from various uranium-bearing ores. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Monday, December 21st, 2020 Uncategorized Comments Off on $UUUU Announces Publication of Sustainability Report, Policy Updates

Cybin Inc. (NEO: CYBN) UK Government Expects Huge Return From Psychedelic Investment

Angel CoFund, an investor backed by the UK government, holds a 5.5% stake in Small Pharma, a London-based neuropharmaceutical company. Small Pharma recently announced that it planned to list the firm on the Toronto Stock Exchange through Unilock Capital Corp, a Canadian capital pool, via reverse takeover.

The company’s objective is to raise $ 15.6 million, an equivalent of C$20 million, which will finance the clinical trial of dimethyltryptamine/DMT-assisted therapy treatment for depression. DMT is an active compound found in ayahuasca, an Amazonian psychedelic brew.

While Angel CoFund is a privately run organization, it is funded by a £100 million ($134 million) loan from the UK Department for Business, Energy and Industrial Strategy. The department recoups the gains made by the investor.

Angel CoFund expects to make a £2 million ($2.69 million) return on its investment once the company lists on the exchange. This means that the UK government will receive a seven-figure return on investment from its indirect investment in Small Pharma. The figures are based on Small Pharma’s prediction valuation, with Small Pharma adding that Angel CoFund had invested in it before the company had commenced its research on psychedelics.

After decades of not conducting research on psychedelic substances because of a general public backlash against psychedelic drugs, research in psychedelic substances and drugs has begun again with renewed zest. A variety of studies focus on the drugs themselves as well as their potential benefits on the human brain and body.

Like many other drugs — such as psilocybinketamine and MDMA — being studied by various biotech groups for their potential to treat PTSD and depression, DMT is still illegal in many nations in the world, including the UK.

However, Small Pharma’s chief executive Peter Rands recently stated in an interview that nearly one-third of the hundreds of millions of individuals across the globe who suffer from depression aren’t responsive to commonly prescribed antidepressant types known as selective serotonin reuptake inhibitors. He observed that the company’s objective is to provide alternative treatment.

Rands noted that the company is working to prove that DMT-assisted therapy could help patients learn to accept and deal with their underlying causes of depression rather than tempering their symptoms, which is what many antidepressants currently on the market do. Rands also stated that while DMT may not be as effectual as psilocybin, it is easier to administrate.

Prior ayahuasca studies have shown that the psychedelic helps to reduce symptoms of depression. However, more extensive placebo-controlled trials of DMT, its active compound, are required in order to convince both regulators and medical professionals of the psychedelic drug’s safety and efficacy.

Many North American companies are also poised to tap the opportunities presented by the emerging psychedelics industry. One such company is Cybin Inc. (NEO: CYBN), which is making inroads into not just the functional mushrooms market but also the medicinal psychedelics space.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Monday, December 21st, 2020 Uncategorized Comments Off on Cybin Inc. (NEO: CYBN) UK Government Expects Huge Return From Psychedelic Investment

$CNPOF Announces Corporate Updates, New Strategic Focus

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Friday provided an update on its 49%-owned joint venture, PharmHouse Inc. Per the update, on Oct. 29, 2020, PharmHouse received a court order from the Ontario Superior Court of Justice to initiate a sale and investment solicitation process (“SISP”) to identify interest in, and opportunities for, a sale of, or investment in, all or part of PharmHouse’s assets or business. This may include a restructuring, recapitalization, or other form of reorganization of PharmHouse’s business and affairs. Phase one of the SISP concluded on Nov. 30, 2020, and a number of non-binding offers were received. PharmHouse, with the assistance of the monitor and the SISP advisor, has selected a number of parties to bring forward to the next phase of the SISP, and binding offers for phase two are due on or about Feb. 16, 2021.

In addition, Canopy Rivers today announced its entry into a definitive agreement with Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) pursuant to which, among other things, Canopy Rivers will transfer three portfolio assets to Canopy Growth in exchange for $115 million in cash and 3,750,000 common shares of Canopy Growth and the cancellation of all 36,468,318 Multiple Voting Shares (“MVS”) and the 15,223,938 Subordinate Voting Shares (“SVS”) of Canopy Rivers held by Canopy Growth (collectively, the “transaction”). On closing, the transaction will result in Canopy Rivers becoming a widely-held company and will unlock substantial value, providing it with significant additional cash resources and allowing it to pursue opportunities in the global cannabis market, including the United States. “This is a transformative transaction for our company that we believe provides substantial value to our shareholders through an enhanced cash position and strategic flexibility, and the collapse of our dual class share structure,” said Narbe Alexandrian, president and CEO of Canopy Rivers. “Following the closing of the transaction, we intend to shift our focus to pursuing other opportunities in the global cannabis market, where we believe that our new strategic focus and substantial balance sheet will allow us to successfully execute our revamped strategic plan.”

To view the full press release, visit http://cnw.fm/U6I4H and http://cnw.fm/PsSOQ

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 18 companies across various segments of the cannabis value chain. The company believes that bringing together people, capital and ideas raises the potential of the entire cannabis industry. By leveraging industry insights, in-house expertise and thesis-driven approach to investing, Canopy Rivers aims to provide shareholders exposure to specialized and disruptive cannabis companies. Canopy Rivers’ mission is to invest in innovators across the cannabis value chain, help them grow, and ultimately create value by guiding these companies towards a monetization event. Together with its portfolio, the company is helping build the cannabis industry of tomorrow, today. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/CNPOF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Monday, December 21st, 2020 Uncategorized Comments Off on $CNPOF Announces Corporate Updates, New Strategic Focus

$RACMF Announces Launch of Digital Connect Health Platform

Loop Insights (TSXV: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, today announced the January 2021 launch of its Digital Connect Health Platform, a fully-integrated digital health care solution designed for both government and private sector. According to the update, the launch comes after continuous discussions and requests from government leaders, both provincial and federal, over the past seven months. “This has been nothing short of a massive undertaking over the past seven months,” said Loop Insights CEO Rob Anson. “In conjunction with key stakeholders who have been expressing the need for continued digital transformation within the health care sector, we have delivered a complete end-to-end digital solution that solves the challenge of decades of siloed data, a lack of connectivity and a lack of access. As a result, Loop provides governments and the private sector with the ability to connect their current legacy and antiquated systems. This is so revolutionary that it has attracted the attention of global technology companies and has positioned Loop for success within health care.”

To view the full press release, visit http://ibn.fm/xd7aK

About Loop Insights Inc.

Loop Insights is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing and contactless solutions to the brick-and-mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network. For more information, visit the company’s website at www.LoopInsights.ai.

NOTE TO INVESTORS: The latest news and updates relating to RACMF are available in the company’s newsroom at http://ibn.fm/RACMF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, December 21st, 2020 Uncategorized Comments Off on $RACMF Announces Launch of Digital Connect Health Platform

$NETE Germany to Leapfrog California as Biggest EV Market

The race towards electrifying the roads is on, and for the most part, Europe has been ahead of the pack. Several countries around the globe have set timelines to ban the sale of new internal-combustion-engine (“ICE”) vehicles; most of those countries are in Europe, including France, Germany, Norway, the Netherlands and Denmark, among others. In September, California Gov. Gavin Newsom announced that by 2035, every new car sold in the state would be emission free, a move that could make California one of the largest electric vehicle (“EV”) markets on the globe.

Germany, however, is poised to surpass California, home to pioneering EV maker Tesla, as the largest EV market this year. According to a report by Schmidt Automotive Research from Berlin, drivers in Germany purchased 98,370 electric cars over the first nine months of 2020, more than a third of the EVs sold in California. This increase in pure electric vehicle sales can be attributed to a slew of recently extended purchase incentives by the government.

In most markets, electric vehicles are too expensive for consumers to buy outright, so authorities have taken to offering purchase incentives to lower the initial cost of purchasing an EV. Germany was already the largest market for electric vehicles in Europe after edging Norway out of the top spot in 2019, although Norway remains the country with the highest per-capita EV penetration in the world. Germany’s incentive program differs from most programs in Europe as it involves subsidies from both the government and the auto industry.

The German government initially offered a €4,000 ($4,863) discount for EVs with a starting price of less than €60,000 ($72,945) with half of the discount being covered by the auto industry. The incentives program was updated in 2019, with electric vehicles that cost less than €40,000 ($48,630) receiving  a €6,000 ($7,294) discount and those going for between €40,000 and €60,000 getting a €5,000 ($6,079) discount. As part of a €5.9 billion ($7.172 billion) post-pandemic stimulus package to stimulate growth in the auto industry, the government updated the EV incentives program again.

Now electric vehicles that cost less than €40,000 get an extra €3,000 discount from the government, bringing the total subsidy to €9,000. EVs that are poised to benefit the most from this discount include Tesla Model 3, BMW i3, Peugeot 208 Electric, Hyundai Ioniq Electric, Hyundai Kona Electric, Kia Nero Electric, Renault Zoe and the yet-to-be-delivered Volkswagen ID.3.

Still on the topic of California’s EV industry, one global fintech company called Net Element (NASDAQ: NETE) is taking steps to merge with California-based EV manufacturer Mullen Technologies Inc. The resulting company from this merger will be interesting to watch.

NOTE TO INVESTORS: The latest news and updates relating to Net Element (NASDAQ: NETE) are available in the company’s newsroom at http://ibn.fm/NETE

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Monday, December 21st, 2020 Uncategorized Comments Off on $NETE Germany to Leapfrog California as Biggest EV Market

$VTGN Announces Proposed Underwritten Public Offering

SOUTH SAN FRANCISCO, Calif., Dec. 17, 2020 — VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders, today announced that it commenced an underwritten public offering of units consisting of its common stock, par value $0.001 per share (the “Common Stock”), and its Series D convertible preferred stock (the “Series D Preferred Stock”). All securities to be sold in the offering are to be sold by VistaGen. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

The Series D Preferred Stock will be initially convertible into a specified number of shares of Common Stock at any time at the option of the holder, provided that no such conversion will be permitted until VistaGen’s stockholders approve an amendment to its articles of incorporation increasing the number of authorized shares of Common Stock in an amount sufficient to permit the conversion in full of the Series D Preferred Stock.

VistaGen intends to use the net proceeds from the offering for research, development and manufacturing and regulatory expenses associated with continuing development of PH94B, PH10, AV-101, and potential drug candidates to expand its CNS pipeline and for other working capital and general corporate purposes.

Jefferies LLC and William Blair & Company, L.L.C. are acting as joint book-running managers for the offering.

The public offering will be made pursuant to a shelf registration statement on Form S-3 (File No. 333-234025), previously filed with the Securities and Exchange Commission (the “SEC”) and declared effective on October 7, 2019. The securities may be offered only by means of a prospectus supplement and accompanying prospectus that form a part of the registration statement. A preliminary prospectus supplement relating to the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov . When available, copies of the preliminary prospectus supplement and the accompanying prospectus relating to the offering may also be obtained by contacting: Jefferies LLC by mail at Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY, 10022 or by telephone at +1 877-547-6340, or by email at Prospectus_Department@Jefferies.com or William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606 or by email at prospectus@williamblair.com or by telephone at +1 800-621-0687.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About VistaGen
VistaGen Therapeutics, Inc. is a biopharmaceutical company committed to developing and commercializing innovative medicines with potential to go beyond the current standard of care for anxiety, depression and other CNS disorders. Each of VistaGen’s three drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date and has therapeutic potential in multiple CNS markets.

Forward-Looking Statements
Certain of the statements made in this press release are forward-looking, such as those, among others, relating to our expectations regarding the completion of the proposed public offering. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include, without limitation, risks and uncertainties related to whether or not we will be able to raise capital through the sale of shares of Common Stock and preferred stock, market and other conditions and the impact of the COVID-19 pandemic, general economic, industry or political conditions in the United States or internationally. There can be no assurance that we will be able to complete the proposed public offering on the anticipated terms, or at all. We will need to raise additional capital to fund our operations and may be unable to raise capital when needed, which would force us to delay, reduce or eliminate our product development programs or commercialization efforts. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release. Other risks and uncertainties include, but are not limited to, issues related to: adverse healthcare reforms and changes of laws and regulations; manufacturing and marketing risks, including risks related to the COVID-19 pandemic, which may include, but are not limited to, unavailability of or delays in delivery of raw materials for manufacture of its CNS drug candidates and difficulty in conducting clinical trials; inadequate and/or untimely supply of one or more of its CNS drug candidates to meet demand; entry of competitive products; and other technical and unexpected hurdles in the development, manufacture and commercialization of its CNS drug candidates, as well as those risks more fully discussed in the section entitled “Risk Factors” in our most recent Annual Report on Form 10-K for the year ended March 31, 2020, and in our most recent Quarterly Report on Form 10-Q for the quarter and six months ended September 30, 2020, as well as discussions of potential risks, uncertainties, and other important factors in our other filings with the SEC. Our SEC filings are available on the SEC’s website at www.sec.gov. In addition, any forward-looking statements represent our views only as of the issuance of this release and should not be relied upon as representing our views as of any subsequent date. We explicitly disclaim any obligation to update any forward-looking statements.

Company Contact
Mark A. McPartland VistaGen Therapeutics Inc.
Phone: +1 (650) 577-3600
Email: IR@vistagen.com

Thursday, December 17th, 2020 Uncategorized Comments Off on $VTGN Announces Proposed Underwritten Public Offering

$WTER 420 with CNW – Arizona Regulators Publish Draft Rules for Recreational Cannabis Industry

Cannabis was one of the clear winners in the November 2020 ballot, with voters in five states approving legislation that allowed some form of cannabis use. Arizona was one of those states. Before to the elections, the traditionally red state had some of the most punitive cannabis policies in the country, with possession of even small amounts of marijuana classified as a felony. On Election Day, Arizonians voted overwhelmingly in favor of Proposition 207, a measure that would allow adults to possess a maximum of one ounce of marijuana as well as grow a maximum of six plants at a time for personal use.

A month later, state regulators have already released draft regulations to implement and run Arizona’s recreational cannabis program. The measure stipulates that the Arizona Department of Health Services, which would be in charge of regulating the cannabis program and issuing licenses, had to accept license applications starting Jan. 19, 2021. As such, regulators have been working hard to create guidelines for the state’s cannabis program within the relatively tight schedule that kicked off once the secretary of state officially certified the election results.

The Department of Health Services is expected to present at least one more version of draft regulations before finalizing the state’s cannabis rules. This version of draft regulations covers the timeline for license approvals, licensing fees, the state regulatory body’s structure, product labeling and other matters. Stakeholders will be able to submit feedback on the regulations via an online survey until Dec. 17, 2020. State regulators will use this feedback to amend and fine tune the cannabis regulations.

Thanks to the state’s experience with medical marijuana (Arizona legalized medical marijuana in 2010), regulators are confident they can draft cannabis regulations within the tight timeline outlined. Samuel Richard, executive director of the Arizona Dispensaries Association, has lauded the Department of Health Services for working hard to create an adult-use program “just a week and a half” after Arizona Governor Doug Ducey certified the election results. Medical marijuana operators in the state have an “open and collaborative” relationship with regulators, he says, and they hope the department will be receptive to their feedback.

The regulations are likely to be amended, he adds, with the Department of Health Services putting out at least one more draft based in the feedback it gets from the public. All in all, the cannabis regulations will not be finalized until early January.

Meanwhile, different cannabis products — not just those containing THC — are establishing themselves on the market elsewhere. For example, The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) sells flavored as well as alkaline water, together with products enriched with CBD.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Thursday, December 17th, 2020 Uncategorized Comments Off on $WTER 420 with CNW – Arizona Regulators Publish Draft Rules for Recreational Cannabis Industry

$SGTM Achieves Key Milestones, Eyes Uplist

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, has achieved several accomplishments as recently published in its financial results for the third quarter of 2020. Among these, the company reported a rise in fiscal revenues to $24.5 million over the first nine months of 2020. A recent article discussing this quotes SGTM’s CEO and Director Tony Raynor in reference to the results. “I am proud of our team and the progress we have made this year in achieving these key milestones,” Raynor said. “We plan to proceed in a similar manner during the remaining quarter and end 2020 on a strong note. In keeping with that aim, we have already completed our two-year audit to commence our Form 10 process, which will enable us to begin 2021 as a fully reporting company and uplist accordingly.”

To view the full article, visit https://ibn.fm/C6ZUv

About Sustainable Green Team Ltd.

Sustainable Green Team, through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The company was established with the objective of providing a solution for the treatment and handling of tree debris, which has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. The company’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting tree debris through its tree services division and collection sites and then, through its processing division, recycling and using that tree debris as a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers. The company plans to expand its operations through a combination of organic-growth and strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified. The company’s customers include governmental, residential and commercial clients.

For additional information regarding SGTM’s operations, expansion plans and production facilities, view the company’s presentation. For more information about the company’s Mulch Manufacturing subsidiary, visit www.MulchMfg.com.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, December 17th, 2020 Uncategorized Comments Off on $SGTM Achieves Key Milestones, Eyes Uplist

$PBIO PCT Platform Selected as ‘Method of Choice’ for Many Global Research Teams

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide biotechnology and other industries, today announced a remarkable convergence of global research teams declaring pivotal new insights into COVID-19 biology and disease processes. According to the update, all teams selected PBI’s Pressure Cycling Technology (“PCT”) platform for critical sample preparation steps to help ensure that the greatest abundance and diversity of reproducible results would be revealed in the thousands of proteins involved in affected biochemical pathways. “The compelling history of scientists worldwide publishing on PBI’s PCT-based Barocycler system has resulted in its establishment as the method of choice for many teams who recognize that no compromise can be allowed in the critical stage of sample preparation as they work to ensure that the most complete, informative, robust and reproducible data are captured,” said Dr. Alexander V. Lazarev, chief science officer of PBI.  “Recent publications and reports from three independent laboratories located on three different continents highlighted the importance of PBI’s highly effective and reproducible PCT sample preparation platform in studies designed to generate a more thorough understanding of the SARS-CoV-2 biology, etiology and human response to infection.”

To view the full press release, visit http://ibn.fm/t4Im4

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling pressure-based solutions for the worldwide life sciences and other industries. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control biomolecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). Pressure BioSciences’ primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, December 17th, 2020 Uncategorized Comments Off on $PBIO PCT Platform Selected as ‘Method of Choice’ for Many Global Research Teams

$POAI Researchers Find Imbalances in Gut Microbiota May Cause Major Depressive Disorder

A groups of investigators from various institutions in China and the United States have discovered a connection between major depressive disorder (MDD) and disturbances in the human gut microbiome. The study was published in the “Science Advances” journal.

The team of researchers studied samples of fecal matter from control groups and patients suffering from MDD. Major depressive disorder, also known as clinical depression, is a mood disorder that brings about a loss of interest or persistent feelings of sadness in an individual. The disorder affects how an individual behaves, thinks or feels, and may cause various physical and emotional problems.

Health practitioners believe that the disorder has a biological origin and is not just a reaction to events. The team of researchers argued that they had discovered evidence that connects symptoms of the disorder to problems with an individual’s gut microbiome. The study involved the collection of fecal samples from 155 individuals who do not have the depressive disorder and 156 individuals who have been diagnosed with MDD.

The scientists then conducted a genetic analysis of each of the samples collected in order to determine the microbes and other materials in the samples. Additionally, the researchers conducted an extensive gas chromatography mass spectrometry analysis on the samples in a bid to discover more about their composition.

The researchers noted that in there were differences in the components that were found in the samples, between those from individuals who did not have the disorder and those who did. Specifically, they discovered 3 bacteriophages, 50 fecal metabolites and 47 bacterial species that were different.

In addition, they also determined that patients with the depressive disorder had lower levels of bacteria from the Blautia and Eubacterium species and higher levels of different bacteria from the Bacteroides genus. This led the researchers to believe that major depressive disorder may be connected to problems with gut microbiome.

The researchers suggest that heightened levels of Bacteroides in the microbiome can explain why a lot of patients who suffer from MDD have associated inflammation and higher cytokine levels. The investigators noted that while the current method used to diagnose MDD is an interview, their findings may be useful in developing an additional test to confirm the disorder. This would be by conducting a screening test to assess for the presence of particular elements in the gut microbiome.

Aside from major depressive disorder, different cancers afflict millions of people around the world, and many companies are hard at work seeking better ways to treat these diseases. One firm that is at the forefront of cancer research is Predictive Oncology (NASDAQ: POAI). This company focuses on using AI and data analytics to develop personalized remedies for cancer sufferers.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, December 17th, 2020 Uncategorized Comments Off on $POAI Researchers Find Imbalances in Gut Microbiota May Cause Major Depressive Disorder

$POAI Leverages Precision Medicine Expertise to Support Oncologists, Improve Patient Outcomes

  • Precision medicine is emerging approach to disease prevention, treatment that incorporates individual’s distinctive characteristics.
  • New approach allows doctors, researchers to predict more accurately which treatments may work better.
  • Helomics’ database, largest of its kind, is comprised of ovarian, head and neck, colon and pancreas tumors.

Science has discovered that thumbprints and DNA aren’t the only biological elements that make individuals unique. In fact, ears, eyes, tongues and even the way a person walks is distinctive, unlike anybody else in the world (https://ibn.fm/SJX27). Moreover, the things that make people different from each other don’t stop at physical characteristics. Predictive Oncology (NASDAQ: POAI) is building a business around precision medicine, an emerging approach to disease prevention and treatment that identifies the variability in genes, environment and lifestyle for each individual, and then uses that information to provide individualized treatments designed to ultimately improve patient outcomes (https://ibn.fm/Va9HX).

“This new approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people,” explains a MedLinePlus article. “It is in contrast to a one-size-fits-all approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.”

POAI realizes that “just genomics” is not enough to deliver personalized therapeutic options. The company believes that a multi-omic approach to disease, or one that gathers data from multiple levels such as genome, epigenome, transcriptome, proteome and metabolome, offers a much greater chance of success. With that in mind, Predictive Oncology is addressing cancer, specifically ovarian cancer, by leveraging the synergies of two of its wholly owned subsidiaries — Helomics and TumorGenesis — to bring precision medicine to the space.

One of POAI’s highest priorities is building multi-omic predictive models of tumor drug response and outcome. The company accomplishes this through its subsidiary Helomics and by using its proprietary TumorSpace knowledge base of 150,000 tumor drug response profiles gathered from more than 15 years of clinical testing.

“We have developed a unique technology that combines our clinically validated primary tumor cell assay and drug response data . . . together with proven artificial intelligence (AI) to allow us to test potential drugs against patient tumor cells, much earlier in the drug discovery process,” the company explains (https://ibn.fm/GRRXb). “We believe this patient-centric approach will significantly improve the success of translating compounds into the clinic, saving time, cost, and most importantly getting therapies to patients more quickly.”

Helomics’ database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. The company’s CLIA-certified lab provides testing that assists oncologists in identifying personalized patient treatment options. TumorGenesis is developing a new approach to growing tumors in the laboratory without the use of rats or mice. This exclusive methodology “fools” the tumor into thinking it is still in the body; therefore, it reacts as it naturally would, increasing the accuracy of the biomarker. These biomarkers are then used in TumorGenesis’ Oncology Capture Technology platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples. The process provides critical information that can be used to develop patient-specific treatment options.

For more information on Predictive Oncology, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, December 17th, 2020 Uncategorized Comments Off on $POAI Leverages Precision Medicine Expertise to Support Oncologists, Improve Patient Outcomes

$UUUU Working to Re-Ignite REE production in the US

NEW YORK, Dec. 17, 2020  — via InvestorWire — Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities.

To view the full publication, “It’s Elemental — Restoring the U.S. Rare Earth Element Supply Chain,” please visit: https://nnw.fm/7GSZE

The United States was once a thriving producer of rare earth elements (REEs), a group of 17 elements deemed critical to clean energy and modern technologies. REEs are used in a bevy of applications including cell phones, computers, electric vehicles, defense equipment, renewable energy systems and more. China has dominated global rare earth markets, driving out competitors and controlling nearly all of the world’s processing capacity. China has wielded this monopoly of the REE supply chain to influence foreign policies, a weaponization that threatens the economic and national security of the U.S. and other countries around the world.

Against this backdrop, the U.S. government is committed to ending its dependence upon China for REEs, and Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR is among the leaders with projects that intend to re-ignite REE production in the U.S., which in Energy Fuels’ case, is expected as soon as early 2021. In December 2020, the company advanced its entry into the REE market by inking a three-year supply agreement with the Chemours Company (NYSE: CC) to acquire a minimum of 2,500 tons per year of natural monazite sand ore, one of the highest-grade and highest-value rare earth minerals in the world.

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant, and anticipates commencing commercial production of rare earth element (“REE”) carbonate in 2021. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, has the ability to produce vanadium when market conditions warrant and is completing final test-work for the production of REE carbonate from various uranium-bearing ores. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the company’s website at www.EnergyFuels.com .

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://nnw.fm/UUUU

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate comm

NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) — via InvestorWire — Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities.

To view the full publication, “It’s Elemental — Restoring the U.S. Rare Earth Element Supply Chain,” please visit: https://nnw.fm/7GSZE

The United States was once a thriving producer of rare earth elements (REEs), a group of 17 elements deemed critical to clean energy and modern technologies. REEs are used in a bevy of applications including cell phones, computers, electric vehicles, defense equipment, renewable energy systems and more. China has dominated global rare earth markets, driving out competitors and controlling nearly all of the world’s processing capacity. China has wielded this monopoly of the REE supply chain to influence foreign policies, a weaponization that threatens the economic and national security of the U.S. and other countries around the world.

Against this backdrop, the U.S. government is committed to ending its dependence upon China for REEs, and Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR is among the leaders with projects that intend to re-ignite REE production in the U.S., which in Energy Fuels’ case, is expected as soon as early 2021. In December 2020, the company advanced its entry into the REE market by inking a three-year supply agreement with the Chemours Company (NYSE: CC) to acquire a minimum of 2,500 tons per year of natural monazite sand ore, one of the highest-grade and highest-value rare earth minerals in the world.

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant, and anticipates commencing commercial production of rare earth element (“REE”) carbonate in 2021. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, has the ability to produce vanadium when market conditions warrant and is completing final test-work for the production of REE carbonate from various uranium-bearing ores. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the company’s website at www.EnergyFuels.com .

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://nnw.fm/UUUU

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness.

NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

unication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness.

NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

Thursday, December 17th, 2020 Uncategorized Comments Off on $UUUU Working to Re-Ignite REE production in the US
Top Small Cap Market News